In cancer, biomarkers are features of the tumor, such as a genetic mutation or the presence of a certain protein. These biomarkers affect how the cancer behaves. Doctors use the results of biomarker testing to make treatment recommendations.

Several organizations, including the American Cancer Society and the LUNGevity Foundation, through the No One Missed campaign, are working to pass laws to require insurance coverage for biomarker testing for people with cancer.

Joanna Fawzy Doran, CEO of Triage Cancer, discusses some of the issues people face getting biomarker testing covered by insurance and how the new laws are helping.

Listen to the episode to hear Joanna talk about: